A carregar...
Overexpression of peroxiredoxin-3 and −5 is a potential biomarker for prognosis in endometrial cancer
Endometrial cancer is the sixth most common cancer in women worldwide. Peroxiredoxins (PRDXs) are antioxidant enzymes that serve important roles in cell differentiation, proliferation, and apoptosis. In the present study, the potential associations between PRDX expression and endometrial cancer were...
Na minha lista:
Publicado no: | Oncol Lett |
---|---|
Main Authors: | , , , , , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
D.A. Spandidos
2018
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5835875/ https://ncbi.nlm.nih.gov/pubmed/29541251 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2018.7909 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|